Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Debt Ratio (2017 - 2025)

Historic Debt Ratio for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to 0.23.

  • Serina Therapeutics' Debt Ratio fell 8449.29% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 8449.29%. This contributed to the annual value of 5.59 for FY2022, which is 3359.71% up from last year.
  • Latest data reveals that Serina Therapeutics reported Debt Ratio of 0.23 as of Q3 2025, which was down 8449.29% from 1.5 recorded in Q3 2024.
  • Serina Therapeutics' Debt Ratio's 5-year high stood at 7.79 during Q3 2022, with a 5-year trough of 0.18 in Q3 2023.
  • Moreover, its 5-year median value for Debt Ratio was 2.69 (2023), whereas its average is 3.1.
  • Its Debt Ratio has fluctuated over the past 5 years, first plummeted by 9766.76% in 2023, then skyrocketed by 72555.68% in 2024.
  • Over the past 5 years, Serina Therapeutics' Debt Ratio (Quarter) stood at 4.19 in 2021, then surged by 33.6% to 5.59 in 2022, then crashed by 96.75% to 0.18 in 2023, then surged by 725.56% to 1.5 in 2024, then crashed by 84.49% to 0.23 in 2025.
  • Its Debt Ratio was 0.23 in Q3 2025, compared to 1.5 in Q3 2024 and 1.04 in Q2 2024.